For this episode of SC@L we’ve given remote recording a go to keep producing the podcast on lockdown!
PhD student Ana Maria Cujba interviews Dr David Willnow from the Spagnoli Group at the CSCRM. They discuss his research into how the pancreas develops in the embryo and how this will develop potential future therapies for diabetes with this knowledge, David’s involvement multidiciplinary Pan3dp initiative , and the challenges of the immune response to regenerative cell therapies.
For more information on David's research and the Spagnoli Lab, follow this link: https://www.spagnolilab.org
view more